Trial Details
COMPLETEDBasic Information
| Clinical ID | c4327 |
|---|---|
| Identifier | NCT00699166 |
| Trial Title | Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: DNK333 |
Participant Information
| Sponsor | Novartis |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2004-04 |
|---|---|
| Primary Completion Date | 2005-09 |
| Completion Date | 2005-09 |